RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 177 filers reported holding RELAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $145,005 | +4151.1% | 22,240 | +5311.2% | 0.00% | – |
Q1 2024 | $3,411 | -98.2% | 411 | -97.6% | 0.00% | -100.0% |
Q4 2023 | $191,574 | +906.2% | 17,400 | +668.6% | 0.00% | +100.0% |
Q3 2023 | $19,040 | -85.4% | 2,264 | -78.2% | 0.00% | -75.0% |
Q2 2023 | $130,147 | +175774.3% | 10,362 | +130.8% | 0.00% | +100.0% |
Q1 2023 | $74 | -52.6% | 4,490 | -56.9% | 0.00% | -66.7% |
Q4 2022 | $156 | -99.9% | 10,406 | +13.6% | 0.01% | +100.0% |
Q3 2022 | $205,000 | -19.3% | 9,161 | -39.7% | 0.00% | -50.0% |
Q2 2022 | $254,000 | +213.6% | 15,181 | +460.6% | 0.01% | +500.0% |
Q1 2022 | $81,000 | -65.4% | 2,708 | -64.4% | 0.00% | -75.0% |
Q4 2021 | $234,000 | -15.2% | 7,609 | -12.9% | 0.00% | -42.9% |
Q3 2021 | $276,000 | +106.0% | 8,740 | +140.3% | 0.01% | +133.3% |
Q2 2021 | $134,000 | +6.3% | 3,637 | -0.5% | 0.00% | +50.0% |
Q1 2021 | $126,000 | -57.3% | 3,657 | -48.4% | 0.00% | -77.8% |
Q4 2020 | $295,000 | +35.3% | 7,084 | +38.3% | 0.01% | +350.0% |
Q3 2020 | $218,000 | – | 5,124 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |